In 2022, the global market for coronary balloon catheters exceeded a valuation of $963 million. Over the forecast period, it is projected to experience a compound annual growth rate (CAGR) of 2.3%, reaching a value exceeding $1.1 billion.
The comprehensive report suite encompasses the global market for coronary balloon catheters, which includes percutaneous transluminal coronary angioplasty (PTCA) balloons and specialty balloons. Specialty balloons encompass cutting and scoring balloons.
Philips entered the market by acquiring Spectranetics, establishing its position primarily in the specialty balloon catheter segment, where it has secured a significant market share.
Medtronic, like other major competitors in the global coronary balloon catheter market, offers a wide range of devices in both the coronary and peripheral markets. This allows the company to strategically bundle products and leverage its position in the competitive landscape.
The comprehensive report suite encompasses the global market for coronary balloon catheters, which includes percutaneous transluminal coronary angioplasty (PTCA) balloons and specialty balloons. Specialty balloons encompass cutting and scoring balloons.
GLOBAL CORONARY BALLOON CATHETER MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Volumes
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
PROCEDURE VOLUMES
As part of our study on the global coronary balloon catheter market, the publisher has conducted a comprehensive analysis of angiography, angioplasty (or PCI), atherectomy, and catheterization procedure volumes. This analysis has been performed to enhance the accuracy of our market sizing and provide you with detailed information on procedure volumes spanning a 10-year timeframe across 70 countries. By incorporating procedure volume data, we aim to provide a comprehensive understanding of the market dynamics and trends in the coronary balloon catheter industry.GLOBAL CORONARY BALLOON CATHETER MARKET INSIGHTS
The primary purpose of coronary balloon catheters is to dilate a vessel before the insertion of a stent. The concerns surrounding late stent thrombosis have contributed to an increase in the number of pre-stent dilation procedures, thereby driving market growth. However, the widespread adoption of drug-eluting stents (DESs) has had a limiting impact on the coronary balloon catheter market. DESs have demonstrated effectiveness in reducing restenosis rates and minimizing the need for pre-stent dilation procedures. While coronary balloon catheters may still be used after DES procedures, the overall reduction in restenosis has resulted in a decrease in unit sales for both percutaneous transluminal coronary angioplasty (PTCA) and specialty balloon catheters.GLOBAL CORONARY BALLOON CATHETER MARKET SHARE INSIGHTS
Boston Scientific holds the top position in the global coronary balloon catheter market, with a strong presence in the percutaneous transluminal coronary angioplasty (PTCA) balloon segment, where it commands a majority share.Philips entered the market by acquiring Spectranetics, establishing its position primarily in the specialty balloon catheter segment, where it has secured a significant market share.
Medtronic, like other major competitors in the global coronary balloon catheter market, offers a wide range of devices in both the coronary and peripheral markets. This allows the company to strategically bundle products and leverage its position in the competitive landscape.
Table of Contents
Coronary Balloon Catheter Market
List of Charts
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific
- Medtronic
- Philips
- Abbott
- MicroPort
- Cardiovascular Systems, Inc.
- Cordis
- Biotronik
